Literature DB >> 6277933

Host-dependent phosphorylation and kinase activity associated with vesicular stomatitis virus.

G M Clinton, N G Guerina, H Y Guo, A S Huang.   

Abstract

Among the protein kinases associated with vesicular stomatitis virus (VSV), one was identified by immunoprecipitation to be pp60src, the transformation-specific product coded for by avian sarcoma virus, or its endogenous cellular homolog. This activity phosphorylated only tyrosine. pp60src was enriched in the membranes, whereas the serine- and threonine-specific kinases were concentrated with viral cores. The content of pp60src in VSV can be manipulated by growing VSV in different host cells. Monolayer baby hamster kidney cells transformed by an avian sarcoma virus produced VSV progeny which contained 7-fold greater pp60src activity than progeny produced by control untransformed or revertant cells. In contrast, suspension cultures of baby hamster kidney cells which produced VSV with increased tyrosine-specific kinase activity did not affect the content of pp60src. When pp60src was specifically increased in cells, the endogenous phosphorylation of tyrosine residues in the VSV matrix M protein was also enhanced, to as much as 20-fold. The phosphorylation of serine or threonine in this protein or in the other VSV phosphoprotein NS was not affected. Cellular tyrosine-specific kinases other than pp60scr did not change the overall phosphorylation pattern of any VSV phosphoproteins. Experiments designed to test the effects of endogenous phosphorylation on the various functions of the M protein failed to detect any significant alterations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277933

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C.

Authors:  A K Gupta; D Blondel; S Choudhary; A K Banerjee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Differential effect of ATP concentration on synthesis of vesicular stomatitis virus leader RNAs and mRNAs.

Authors:  J D Beckes; A A Haller; J Perrault
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  Tyrosyl and cyclic AMP-dependent protein kinase activities in BHK cells that express viral pp60src.

Authors:  G M Clinton; R Roskoski
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

4.  Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity.

Authors:  M F Lin; G M Clinton
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

5.  Phosphorylation of NS protein by vesicular stomatitis virus nucleocapsids: lack of effect during RNA synthesis and separation of kinase from L protein.

Authors:  D M Massey; N Deans; J Lenard
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

6.  Inhibition of vesicular stomatitis virus RNA synthesis by protein hyperphosphorylation.

Authors:  T L Chang; C S Reiss; A S Huang
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Intracellular distribution of input vesicular stomatitis virus proteins after uncoating.

Authors:  K D Rigaut; D E Birk; J Lenard
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  CDC7-dependent protein kinase activity in yeast replicative-complex preparations.

Authors:  S M Jazwinski
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation.

Authors:  S Barik; A K Banerjee
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Viral products in cells infected with vesicular stomatitis virus and superinfected with Rous sarcoma virus.

Authors:  M Semmel; G Mercier; N Pavloff; G Dambrine; F Gay; J M Biquard
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.